Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- KU LEUVEN
- University of Antwerp
- Ghent University
- University of Leuven
- Nature Careers
- KU Leuven
- Université Catholique de Louvain (UCL)
- VIB
- Vrije Universiteit Brussel
- Vrije Universiteit Brussel (VUB)
- BIO BASE EUROPE PILOT PLANT VZW
- Flanders Institute for Biotechnology
- Hasselt University
- IMEC
- Katholieke Universiteit Leuven
- University of Liège
- Université Libre de Bruxelles (ULB)
- Université catholique de Louvain
- Université catholique de Louvain (UCL)
- 9 more »
- « less
-
Field
-
to work and thinking. For more information please contact Prof. dr. Patrick Wagner, tel.: +32 16 32 21 79, mail: patrickhermann.wagner@kuleuven.be . Where to apply Website https://www.kuleuven.be/personeel
-
Martelarenlaan 42 Postal Code 3500 E-Mail jobs@uhasselt.be Phone 011268049 STATUS: EXPIRED X (formerly Twitter) Facebook LinkedIn Whatsapp More share options E-mail Pocket Viadeo Gmail Weibo Blogger Qzone
-
-weekly basis. If you are eligible after review, you will be invited for an interview. If you have any questions about the online application form, please check the frequently asked questions or send
-
Ibrahim at j.ibrahim@qurin.com . If you have any questions about the online application form, please check the Frequently Asked Questions or send an email to jobs@uantwerp.be . The University of Antwerp is
-
share options E-mail Pocket Viadeo Gmail Weibo Blogger Qzone YahooMail
-
or send an email to jobs@uantwerpen.be . If you have any questions about the job itself, please contact Sebastiaan.deschepper@uantwerpen.be The University of Antwerp received the European Commission’s HR
-
questions or send an email to jobs@uantwerpen.be . If you have any questions about the job itself, please contact Siegfried Mercelis siegfried.mercelis@uantwerpen.be The University of Antwerp received
-
patients’ brain, molecular diagnosis during life remains challenging due to the lack of reliable biomarkers for in vivo assessment. Moreover, post-mortem studies have revealed significant molecular
-
@UGent.be . The promoter and co-promoter (if applicable) are included in this e-mail (either as sender, or in CC).
-
assessment. Moreover, post-mortem studies have revealed significant molecular heterogeneity, suggesting the existence of distinct neuropathological subtypes within each disease. Stratifying patients